Adjuvant therapy for gastric cancer: what have we learned since INT0116?

@article{Jcome2015AdjuvantTF,
  title={Adjuvant therapy for gastric cancer: what have we learned since INT0116?},
  author={Alexandre A. A. J{\'a}come and Ajith K. Sankarankutty and Jos{\'e} Sebasti{\~a}o dos Santos},
  journal={World journal of gastroenterology},
  year={2015},
  volume={21 13},
  pages={3850-9}
}
Gastric cancer is one of the main cancer-related causes of death worldwide. The curative treatment of gastric cancer consists of tumor resection and lymphadenectomy. However, surgical treatment alone is associated with high recurrence rates. Adjuvant treatment strategies have been studied over the last decades, but there have been controversial results from the initial studies. The pivotal INT0116 study demonstrated that the use of adjuvant chemoradiotherapy with 5-fluorouracil increases… CONTINUE READING